2023 Annual Meeting | P11 - Poster Session 11

Date Wednesday 04/26/23

Time 11:45 AM - 12:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)

CME Available 0.00 CME credit

Event Timeline
11:45 AM - 12:45 PM EST	Abstract	9-001 - Fenfluramine Treatment Is Associated With Improvement in Everyday Executive Function in Adults With Lennox-Gastaut Syndrome: Post-Hoc Analysis of Dose Effects From a Phase 3 Trial Rationale Kelly G. Knupp, MD
11:45 AM - 12:45 PM EST	Abstract	9-002 - Efficacy of Soticlestat Treatment by Seizure Type in Patients with Dravet Syndrome or Lennox–Gastaut Syndrome in a Phase 2, Randomized, Placebo-controlled Study (ELEKTRA) Naga V. Pathi Jagannatham, MD
11:45 AM - 12:45 PM EST	Abstract	9-003 - 12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis Herbert Peeples II, Other
11:45 AM - 12:45 PM EST	Abstract	9-004 - Early and Sustained Treatment Effect of Adjunctive Perampanel in Patients with Seizures Associated with Lennox-Gastaut Syndrome (LGS): A Post Hoc Analysis Stella L. Ngo, PhD
11:45 AM - 12:45 PM EST	Abstract	9-005 - Long-Term Efficacy of Perampanel Monotherapy in Patients with Newly Diagnosed/Currently Untreated Recurrent Focal-Onset Seizures: FREEDOM Study 342 Extension Phase Analysis by Seizure Type Marcia E. Morita-Sherman, MD
11:45 AM - 12:45 PM EST	Abstract	9-006 - Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study Sami M. Aboumatar, MD
11:45 AM - 12:45 PM EST	Abstract	9-007 - Effects of Cenobamate on Weight: Post-hoc Analyses of Global Phase 2 and 3 Studies Louis Ferrari
11:45 AM - 12:45 PM EST	Abstract	9-008 - Perampanel for Treatment of Focal and Generalized Epilepsy in Everyday Clinical Practice: Evidence from PERMIT and PROVE Stella L. Ngo, PhD
11:45 AM - 12:45 PM EST	Abstract	9-009 - Long-Term Quality of Life in Patients With Focal Seizures Treated With ESL: Pooled Analysis From 3 Phase III Open-Label Extension Studies David Cantu, PhD
11:45 AM - 12:45 PM EST	Abstract	9-010 - Effectiveness and Tolerability of Brivaracetam by Number of Lifetime Antiseizure Medications in Adults with Focal Onset Seizures: Pooled Data From Two Real-world Studies Mallory Alonso, PharmD
11:45 AM - 12:45 PM EST	Abstract	9-011 - ELEVATE Study 410: Assessment of Cognition (EpiTrack®) Following Perampanel (Monotherapy/First Adjunctive) in Patients with Epilepsy and a History of Psychiatric/Behavioral Events Stella L. Ngo, PhD
11:45 AM - 12:45 PM EST	Abstract	9-012 - A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of XEN1101 as an Adjunctive Therapy in the Treatment of Primary Generalized Tonic-Clonic Seizures Cynthia L. Harden, MD
11:45 AM - 12:45 PM EST	Abstract	15-001 - Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review
11:45 AM - 12:45 PM EST	Abstract	15-002 - Novel BIPOC+ Next-Generation Summer Neuroscience Research Internship Initiative Ka-Ho Wong
11:45 AM - 12:45 PM EST	Abstract	15-003 - An Advocacy Leadership Training in Neurology for High School Students: A Pilot Study Tyler A. Gumpel
11:45 AM - 12:45 PM EST	Abstract	15-005 - How to Increase the Neurology Pipeline? A Critical Systematic Review of K-12 Neurology Pipeline Programs
11:45 AM - 12:45 PM EST	Abstract	15-006 - Preclinical Neuroscience Education: Planting the Seed for a Career in Neurology Jeremy Laukka, PhD
11:45 AM - 12:45 PM EST	Abstract	3-001 - Longitudinal Brain Volume Findings in an Outpatient Practice of Young People with MS Kimberly O'Neill, MD
11:45 AM - 12:45 PM EST	Abstract	3-002 - Multifaceted Evaluation of Double Inversion Recovery Brain MRI in Detection of Cervical Spine Multiple Sclerosis Lesions Shivam Patel, MD
11:45 AM - 12:45 PM EST	Abstract	3-003 - Functional and Structural MRI Changes Associated With Cognitive Worsening in Multiple Sclerosis: A 3-Year Longitudinal Study Paolo Preziosa
11:45 AM - 12:45 PM EST	Abstract	3-004 - Early detection of silent brain function changes in multiple sclerosis using magnetoencephalography (MEG): Towards an imaging biomarker Mouhamad Hammami
11:45 AM - 12:45 PM EST	Abstract	3-005 - Quantitative brain 18F-FDG PET/CT analysis in seronegative autoimmune encephalitis Samantha Roman, MD
11:45 AM - 12:45 PM EST	Abstract	3-006 - Deep Learning Reconstruction of Lesion-Free Representations of the Brain in Multiple Sclerosis Patients Despoina Ioannidou, PhD
11:45 AM - 12:45 PM EST	Abstract	3-007 - Neural effects of fatigue on cognition in relapsing multiple sclerosis detected by magnetoencephalography: Towards an imaging biomarker Anza B. Memon, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-008 - The Challenges of MRI in Clinical Practice Cortnee Roman, NP, DAAN
11:45 AM - 12:45 PM EST	Abstract	3-009 - Imaging Chronic Active Lesions in Multiple Sclerosis: a Consensus Statement from the North America Imaging in Multiple Sclerosis Cooperative Francesca Bagnato, MD
11:45 AM - 12:45 PM EST	Abstract	3-010 - Predicting MRI Changes in Patients with MS in the Absence of Acute Inflammation Nolan Campbell
11:45 AM - 12:45 PM EST	Abstract	3-011 - Impact of natalizumab on chronic active lesions Marjo Nylund
11:45 AM - 12:45 PM EST	Abstract	3-012 - Association between retinal layer thickness and cortical lesions at the onset of clinically isolated syndrome Kyriakoula Varmpompiti, MBBS
11:45 AM - 12:45 PM EST	Abstract	3-013 - International Consensus on Smoldering Disease in Multiple Sclerosis using the Delphi Method Francesca Bagnato, MD
11:45 AM - 12:45 PM EST	Abstract	3-014 - TMS Targets for Multiple Sclerosis Related Depression Derived Using a Precomputed Functional Connectome William Drew
11:45 AM - 12:45 PM EST	Abstract	3-015 - Exploring New Imaging Biomarkers: 3D Conformational Analysis Of The Medulla And Upper Cervical Spinal Cord In People With Relapsing Multiple Sclerosis Tatum Moog
11:45 AM - 12:45 PM EST	Abstract	3-016 - Overlapping and Distinguishing Features Among MS, NMOSD, MOGAD and Other Atypical Demyelinating Syndromes of the Central Nervous System Bade Gulec
11:45 AM - 12:45 PM EST	Abstract	3-017 - African Americans with multiple sclerosis (MS) are more likely to have paramagnetic rim lesions (PRLs) compared to Caucasians Nara Michaelson, MD
11:45 AM - 12:45 PM EST	Abstract	3-018 - Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis Omri Zveik, MD
11:45 AM - 12:45 PM EST	Abstract	12-001 - Neurologic Implications of Spaceflight Mark Rosenberg, MD
11:45 AM - 12:45 PM EST	Abstract	12-002 - Infratentorial Superficial Siderosis and Spontaneous Intracranial Hypotension: Type, Time course, and Treatment of underlying Spinal Cerebrospinal Fluid Leak. Jennifer Harris, MD
11:45 AM - 12:45 PM EST	Abstract	12-003 - Orthostatic Hemifacial Spasm, Trigeminal Paresthesias, and Pulsatile Tinnitus in the Setting of Idiopathic Intracranial Hypertension Madison M. Patrick
11:45 AM - 12:45 PM EST	Abstract	12-004 - Gauging the pressure: The clinical dilemma with Chiari! Elelia Phillips, MD
11:45 AM - 12:45 PM EST	Abstract	12-006 - A Case of Pantothenate Kinase-Associated Neurodegeneration (PKAN) in a Patient with One Known Pathologic Variant and One Variant of Unknown Significance Bryn Rubin, MD
11:45 AM - 12:45 PM EST	Abstract	12-007 - A Comparison of Phenotypic and Genotypic Features in Identical Twins with Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like Episodes (MELAS) Joyce Mbiziwo-Tiapo, MD
11:45 AM - 12:45 PM EST	Abstract	6-001 - Optical Coherence Tomography Angiography (OCTA) Retinal Imaging Can Detect Burden of Small Vessel Disease and Amyloid Deposition in the Brain Camilo Bermudez, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	6-002 - Remote Ischemic Conditioning with Novel Optical Sensor Feedback Device in Acute Ischemic Stroke- a feasibility study Robert Joseph C. Sarmiento, MD
11:45 AM - 12:45 PM EST	Abstract	6-003 - 3-Dimensional Subcortical Vascular Maps Sally S. Ladsaria, MD
11:45 AM - 12:45 PM EST	Abstract	6-006 - White matter disease and recovery following endovascular thrombectomy after acute ischemic stroke Nicholas Vigilante III, MD
11:45 AM - 12:45 PM EST	Abstract	6-007 - Clinical and Radiological Features of Intracerebral Hemorrhage in Pregnant and Postpartum Patients Mehriban Sariyeva
11:45 AM - 12:45 PM EST	Abstract	6-008 - Evaluation of Imaging Techniques for the Measurement of Extracranial Internal Carotid Stenosis: A Systematic Scoping Review. Marc Lawrence, MD
11:45 AM - 12:45 PM EST	Abstract	6-009 - Framingham Risk Score and White Matter Disease Progression Hossam Youssef, MD
11:45 AM - 12:45 PM EST	Abstract	6-010 - Expediting emergent MRI in acute ischemic stroke by extending CT scout image: a simple intervention to decrease time to treatment Yasmin Aghajan, MD
11:45 AM - 12:45 PM EST	Abstract	6-011 - Multi-territorial Acute Ischemic Stroke with low T2* signal—an MRI marker for differentiating infective endocarditis from cancer-related stroke Akira Machida, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	6-013 - Penumbra without core in acute hemispheric stroke syndrome: an imaging biomarker for underlying atherosclerotic intracranial stenosis Gyanendra Kumar, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-014 - To Investigate When and What to Do for Deep Subcortical White Matter Hyperintensity (DSWMH) in a Large Cohort Study Yoshinori Nishimoto
11:45 AM - 12:45 PM EST	Abstract	6-015 - A Cross-Sectional Study of Home Blood Pressure Monitoring after Stroke Melissa Mariscal, MD
11:45 AM - 12:45 PM EST	Abstract	6-016 - Identifying optimal cut points of National Institutes of Health Stroke Scale to Predict Mortality: A Population-based Assessment Robert Stanton II, MD
11:45 AM - 12:45 PM EST	Abstract	6-017 - Ischemic Changes in Carotid Endarterectomies are More Severe in Left-Sided Procedures Amir Mina
11:45 AM - 12:45 PM EST	Abstract	6-018 - Diagnosis and Prognosis of Stroke Using Artificial Intelligence and Imaging Kathleen Miao
11:45 AM - 12:45 PM EST	Abstract	6-019 - Stroke and Transient Ischemic Attack Care Transitions Clinic: Providing Timely, Evidence-Based Care Shivani Daryani, PA
11:45 AM - 12:45 PM EST	Abstract	6-020 - A Systematic Review on the Duration of Antipsychotic Exposure and the Risk of Cerebrovascular Events in Elderly Patients Gregory P. Devine, MD
11:45 AM - 12:45 PM EST	Abstract	6-021 - Very early neurological deterioration after thrombolysis Ying-Chi S. Shen, MD
11:45 AM - 12:45 PM EST	Abstract	6-022 - Distinct lesion features and underlying mechanisms in patients with acute multiple infarcts in multiple cerebral circulations
11:45 AM - 12:45 PM EST	Abstract	6-023 - Stroke Etiology of Large Vessel Occlusion Acute Ischemic Stroke (LVO-AIS) In a Racially Diverse Young Adult Cohort Using ASCOD Classification Jonathan W. Handshoe, MD
11:45 AM - 12:45 PM EST	Abstract	6-024 - Multidisciplinary approach to Patent Foramen Ovale (PFO) closure for Cryptogenic Stroke: Brain-Heart Board Experience Muhib Khan, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-025 - Vascular risk factors, cerebral collateral efficiency and burden of small vessel disease in anterior circulation large vessel occlusion stroke Nadia McMillan, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	6-026 - Case Series of Apixaban Failure in Active Cancer Patients Muhammad I. Yousaf, MD
11:45 AM - 12:45 PM EST	Abstract	6-027 - LACE+ is marginally predictive of 30-day readmission after stroke Muhib Khan, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-028 - Clinical Review 32 Cases of Medullary Infarction from a Tertiary Center Prasanna Venkatesan Eswaradass, MD
11:45 AM - 12:45 PM EST	Abstract	6-030 - Association of Co-morbidities with Functional Outcomes in Stroke Patients with Atrial Fibrillation on long-term Oral anticoagulation Mohammad A. Sheikh, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-031 - Quality of Life and Emotional Health of Stroke Survivors and Caregiver After Stroke Camp Dhara Mehta, DO
11:45 AM - 12:45 PM EST	Abstract	6-032 - Diagnostic Yield of Extended Cardiac Patch Monitoring in Cryptogenic Stroke Patients Victoria Rice, DO
11:45 AM - 12:45 PM EST	Abstract	7-001 - Stepwise functional brain architecture from disease epicenter correlates with atrophy in progressive supranuclear palsy Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM EST	Abstract	7-002 - Volumetric Analysis of Hippocampal Subregions and Subfields in Left and Right Predominant Semantic Dementia Arenn Faye Carlos, MD
11:45 AM - 12:45 PM EST	Abstract	7-003 - Characterization of FTLD spectrum through advanced diffusion-weighted MRI metrics: a connectome approach Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM EST	Abstract	7-004 - 123I-Ioflupane SPECT Striatal Binding Ratio Predicts Progression of Parkinsonism in a Dementia with Lewy Bodies Cohort Emily Maly, MD
11:45 AM - 12:45 PM EST	Abstract	7-005 - Early detection of mild cognitive impairment (MCI) using MEG Mouhamad Hammami
11:45 AM - 12:45 PM EST	Abstract	7-006 - APOE e4 Influences Within and Between Network Functional Connectivity in Atypical Alzheimer Disease Neha Atulkumar Singh, PhD
11:45 AM - 12:45 PM EST	Abstract	7-007 - Periventricular White Matter Fractional Anisotropy as a Biomarker of Cerebral Small Vessel Disease Banafsheh Shakibajahromi, MD
11:45 AM - 12:45 PM EST	Abstract	7-008 - Age - related vulnerability of the human brain connectome Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM EST	Abstract	7-009 - Effect of Amyloid PET on Clinical Management of Alzheimer's Disease Medication Therapy: The Khatib Study Taylor Ariko
11:45 AM - 12:45 PM EST	Abstract	1-001 - Validation of a Non-Invasive Method Using Mechanical Extensometer for the Estimation of Intracranial Compliance Using Repeated Measures Agreement Analysis Hayley G. Williams, MD
11:45 AM - 12:45 PM EST	Abstract	1-002 - Hypertonic Saline Solution versus Mannitol in Children with Intracranial Hypertension: A Systematic Review and Meta-Analysis Artur Menegaz de Almeida, MS
11:45 AM - 12:45 PM EST	Abstract	1-003 - Functional near-infrared spectroscopy as a tool to assess residual and covert consciousness in the intensive care unit Karnig Kazazian, PhD
11:45 AM - 12:45 PM EST	Abstract	1-004 - The Use of Standardized Interpretation & Reporting for Multimodality Neuromonitoring Rudy Luna, MD
11:45 AM - 12:45 PM EST	Abstract	1-005 - Quantitative Pupillometry is Not Impacted By IV Opioid or Sedative Bolus Dosing Joshua Battley, MD
11:45 AM - 12:45 PM EST	Abstract	1-006 - Quantitative Pupillometry in Patients with Surgical Decompression Ciara Hupp, MD
11:45 AM - 12:45 PM EST	Abstract	10-001 - Sural Nerve Biopsy Assessment by Individual Histologic Preparations: An Observational Cohort Study of 100 Consecutive Cases Pannathat Soontrapa, MD
11:45 AM - 12:45 PM EST	Abstract	10-002 - Multiparametric Quantitative MRI of Peripheral Nerves to Differentiate Axonal from Demyelinating Neuropathies Yongsheng Chen, PhD
11:45 AM - 12:45 PM EST	Abstract	10-003 - Genotypic And Phenotypic Features of Patients with GJB1 Mutations: Single Center Experience Fatma Yesim Parman, MD
11:45 AM - 12:45 PM EST	Abstract	10-004 - Neuropathy as an adverse effect of proteasomal inhibitors in multiple myeloma treatment: a network meta-analysis Anisha Garg, MD
11:45 AM - 12:45 PM EST	Abstract	10-005 - Peripheral Nerve Pathology in Antibody Positive Paraneoplastic Neurological Syndromes Andre Granger, MD, MBA
11:45 AM - 12:45 PM EST	Abstract	10-006 - Novel Biomarker for Demyelination in Diabetic Distal Symmetric Polyneuropathy: A Prospective Study Kazim Jaffry
11:45 AM - 12:45 PM EST	Abstract	10-007 - Characteristics of Carpal Tunnel Syndrome in Wild-Type Transthyretin Amyloidosis Angela Russell, MD
11:45 AM - 12:45 PM EST	Abstract	10-009 - Single Center Experience of RETREG1-related Hereditary Sensory Autonomic Neuropathy in Turkey Arman Cakar
11:45 AM - 12:45 PM EST	Abstract	10-010 - Clinical features and real-world outcomes of Guillain–Barré syndrome in the Philippines Adrian I. Espiritu, MD
11:45 AM - 12:45 PM EST	Abstract	10-011 - Motor Nerve Conduction Slowing in Diabetic Distal Symmetrical Polyneuropathy: A Novel Approach Mustafa Jaffry
11:45 AM - 12:45 PM EST	Abstract	10-012 - Kappa Light Chain Deposition Disease Presenting with Axonal Sensorimotor Polyneuropathy in the Absence of Clinically Significant Renal Pathology Nadia Khalil, MD
11:45 AM - 12:45 PM EST	Abstract	10-013 - Clinical Implications of Specific Autoantibodies in Chronic Inflammatory Neuropathies Victor Bushlyar, MD
11:45 AM - 12:45 PM EST	Abstract	10-014 - Expanded Reference Tissue Methylome for Tissue-of-origin Deconvolution of Cell-free DNA in Plasma from ALS Patients Mai Yamakawa, MD
11:45 AM - 12:45 PM EST	Abstract	10-015 - Presence of deep tendon reflexes may not exclude a diagnosis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) James Strathdee, MBBS
11:45 AM - 12:45 PM EST	Abstract	4-001 - Implementation of Depression Screening and Interventions Protocol in a Pediatric Neurology Residents’ Continuity Clinic: A Quality Improvement Project Purva Choudhari, MD
11:45 AM - 12:45 PM EST	Abstract	4-003 - Social Behavioral Impairments in SYNGAP1-related Intellectual Disability Hajera Naveed
11:45 AM - 12:45 PM EST	Abstract	4-004 - A Cross-Sectional Study of the Neuropsychiatric Phenotype of CACNA1C-Related Disorder Rebecca J. Levy, MD
11:45 AM - 12:45 PM EST	Abstract	4-005 - Sandman Send Me a Dream: Case of Non-24-Hour Sleep-Wake Disorder in a Sighted Pediatric Patient Matthew Hart, MD
11:45 AM - 12:45 PM EST	Abstract	4-006 - Acute psychosis as initial presentation for Neurofibromatosis Type 2 Jason S. Gill, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	4-007 - Adding Tools to Our Toolkit: How to Care for Children with Autism and Challenging Behaviors Christina Massrey, MD
11:45 AM - 12:45 PM EST	Abstract	4-008 - Mitochondrial Complex I Deficiency Associated with Biallelic NDUFA13 Variants Lead to Leigh Syndrome Rauan Kaiyrzhanov, MD
11:45 AM - 12:45 PM EST	Abstract	4-009 - Scurvy presenting with difficulties to walk and weakness in pediatric patients; 2 case reports. Anastasia Railean, MD
11:45 AM - 12:45 PM EST	Abstract	4-010 - “Confounding Contractures” A Non-Lethal Presentation of a Lethal Disorder
11:45 AM - 12:45 PM EST	Abstract	4-011 - Large-Cohort Characterization of Pediatric Small Fiber Neuropathy Alexander J. Mills
11:45 AM - 12:45 PM EST	Abstract	4-012 - Disease Impact and Burden in Patients with SCN2A-Related Developmental and Epileptic Encephalopathy Brian Pfister
11:45 AM - 12:45 PM EST	Abstract	13-001 - Rapid Reversal of Locked-in Syndrome from Acute Neuroinvasive West Nile Virus with High-dose Steroids Sumayya Mohammed, MD
11:45 AM - 12:45 PM EST	Abstract	13-002 - A Case of Monkeypox-associated Encephalomyelitis—Colorado, July–August, 2022 Kelli Money, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	13-003 - Neurological Manifestations of Human Monkeypox: A Systematic Review Bahadar S. Srichawla, DO, MS
11:45 AM - 12:45 PM EST	Abstract	13-004 - Neuroinvasive Manifestations of West Nile Virus Infection: Lumbar Polyneuropathy, Chorioretinal Lesions, Sensorineural Hearing Loss Matthew W. Flounders, DO
11:45 AM - 12:45 PM EST	Abstract	13-005 - Persistent CMV in Brain Tissue of a Patient with Congenital CMV Following Resolution of Viremia Jeffrey Kuerbitz, PhD
11:45 AM - 12:45 PM EST	Abstract	13-006 - HHV-7 Encephalitis: The Rare Infection and Its Outcome on a Child Ítalo B. Andrade
11:45 AM - 12:45 PM EST	Abstract	5-001 - Deep Brain Stimulation of the Subthalamic Nucleus in a Patient With X-Linked Dystonia-Parkinsonism. Sviatoslav Redko, MD
11:45 AM - 12:45 PM EST	Abstract	5-002 - Improvement in Cervical Dystonia – Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation (DBS) Alberto Albanese, MD
11:45 AM - 12:45 PM EST	Abstract	5-003 - Long-term Safety of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia in Phase 3, Open-label, Multicenter ASPEN-OLS Trial Todd Gross
11:45 AM - 12:45 PM EST	Abstract	5-004 - Dystonia is Associated with Macro and Microstructural Abnormalities of the Cerebellum: Analysis of Volumetric and Diffusion-Weighted MRI Data in the UK Biobank. Xenos Mason, MD
11:45 AM - 12:45 PM EST	Abstract	5-005 - Clinical and Pathological Characterization of VPS16 Dystonia Mariel Pullman, MD
11:45 AM - 12:45 PM EST	Abstract	5-006 - Efficacy and Safety of DaxibotulinumtoxinA for Injection Over Successive Treatments in Adults With Cervical Dystonia in the Phase 3 ASPEN-1 and ASPEN-OLS Trials Todd Gross
11:45 AM - 12:45 PM EST	Abstract	5-008 - Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant Nikolai Gil D. Reyes, MD
11:45 AM - 12:45 PM EST	Abstract	5-009 - Wearable device to measure disease severity in cervical dystonia Shameer Rafee, MBBS
11:45 AM - 12:45 PM EST	Abstract	5-010 - Global Improvements and Psychiatric Stability in Adults with Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies Olga Klepitskaya, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	5-011 - Symptom severity, impairment and health outcomes in patients with Functional Tic Like Behaviours Lindsay Berg, Other
11:45 AM - 12:45 PM EST	Abstract	5-012 - Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia Eric Jen
11:45 AM - 12:45 PM EST	Abstract	5-013 - The Association Between Gender Minority Identity and Functional Tic-Like Behaviors During the COVID-19 Pandemic Davide Martino, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	5-014 - Characterizing Functional Tics Anh-Tho Antoinette T. Nguyen
11:45 AM - 12:45 PM EST	Abstract	5-015 - Etiological factors associated with functional tic-like behaviours during the COVID-19 pandemic Lindsay Berg, Other
11:45 AM - 12:45 PM EST	Abstract	5-016 - Black and Hispanic Individuals with Tourette Syndrome are Under-Represented in Specialty Clinics Marisela E. Dy-Hollins, MD, MSCR, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-001 - A Cross-Sectional Survey of Prevailing Opinions from Headache Specialists Regarding Status Migrainosus Management Jennifer V. Robblee, MD
11:45 AM - 12:45 PM EST	Abstract	2-002 - Botulinum Toxin Off Label Use in Chronic Migraine Patients: An American Headache Society Clinical Survey Study Ashhar Ali, DO, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-003 - Clinical features and ICHD headache diagnoses for patients with prominent craniofacial pain referred by a rhinologist to headache specialists Odei Alayyas, MD
11:45 AM - 12:45 PM EST	Abstract	2-004 - Positive Establishment of a Digital Working Alliance with a Prescription Digital Therapeutic in Patients with Migraine Shaheen E. Lakhan, MD, PhD, MEd, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-005 - Cervical Dystonia in a Headache Population: General Medical Education (GME) Training to Standardize Screening Ryoichi Inoue, MD
11:45 AM - 12:45 PM EST	Abstract	2-006 - Real-world Treatment Combinations of Migraine-specific Prescription Medications Ali Mohajer, PhD
11:45 AM - 12:45 PM EST	Abstract	2-007 - ZAPTed (Zygomatic Arch and Point Triggers) Protocol for Botulinum Toxin Injections in the Management of Refractory Trigeminal Neuralgia Arun Aggarwal, FRACP
11:45 AM - 12:45 PM EST	Abstract	2-008 - Continuous Ketamine Infusion for Treatment of Refractory Headache in the Inpatient Setting
11:45 AM - 12:45 PM EST	Abstract	2-009 - A History of Abuse is Associated with More Severe Migraine- and Pain-Related Disability: Results from the American Registry of Migraine Research (ARMR) Meesha Trivedi
11:45 AM - 12:45 PM EST	Abstract	2-010 - Prevalence and risk factors of primary headache disorders among Healthcare professionals in México, results of a multicenter survey Rodolfo M. Roman Guzman, Sr., MD
11:45 AM - 12:45 PM EST	Abstract	2-012 - Headache in acute ischemic stroke. Results from two Mexican databases. Alejandro R. Marfil-Rivera, MD
11:45 AM - 12:45 PM EST	Abstract	11-001 - Low-dose radiation followed by on-target inhibition of Galectin-3 in combination with anti-4-1BB monoclonal antibody regulates immune responses in Group 3 and Group 4 medulloblastoma mouse model David Cachia, MD
11:45 AM - 12:45 PM EST	Abstract	11-002 - Cell Lineage and Pseudotime Inference for Single-cell Transcriptomics Analysis of Chemoresistance in GBM Isabelle Preddy, MD
11:45 AM - 12:45 PM EST	Abstract	11-003 - Patient-Derived Organoids Recapitulate Intrinsic Immune Landscapes and Progenitor Populations of Glioblastoma. Fumihiro Watanabe
11:45 AM - 12:45 PM EST	Abstract	11-004 - Modeling of Aryl Hydrocarbon Receptor Pathway Intrinsic Immunometabolic Role using Glioblastoma Stem Cells and Patient-Derived Organoids Fumihiro Watanabe
11:45 AM - 12:45 PM EST	Abstract	11-005 - Co-targeting CK1ε and PIK3CB/p110ß as a Therapeutic Approach for Glioblastoma. Eileen Xu

Faculty Disclosures
Dennis J. Dlugos, MD	Dr. Dlugos has received research support from NIH. The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Kathleen B. Digre, MD, FAAN	Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Virgilio Gerald H. Evidente, MD, FAAN	Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. The institution of Dr. Evidente has received research support from Vima Pharmaceuticals. The institution of Dr. Evidente has received research support from Biohaven.
Laurie J. Ozelius, PhD	The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Magdy H. Selim, MD, PhD	Dr. Selim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Selim has received research support from NIH/NINDS. Dr. Selim has received publishing royalties from a publication relating to health care.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Kenneth L. Tyler, MD, FAAN	Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Randolph S. Marshall, MD, FAAN	The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Brett M. Kissela, MD, MS, FAAN	The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.
R E. Faught, Jr., MD, FAAN	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Anne Louise Oaklander, MD, PhD, FAAN	The institution of Dr. Oaklander has received research support from National Institutes of Health.
John A. Detre, MD	Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Roger E. Kelley, Jr., MD, FAAN	Dr. Kelley has nothing to disclose.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Nancy L. Sicotte, MD, FAAN	The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Olga Klepitskaya, MD, FAAN	Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Klepitskaya has or had stock in Neurocrine Biosciences.
Robert T. Wechsler, MD, PhD, FAAN	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Aneesh B. Singhal, MD, FAAN	An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (Education) with Biogen.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Michelle L. Mauermann, MD, FAAN	The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Carlos Singer, MD	Dr. Singer has nothing to disclose.
Timothy Lesnick	No disclosure on file
James E. Galvin, MD, MPH	Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Todd J. Schwedt, MD, FAAN	Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Schwedt has or had stock in Nocira.Dr. Schwedt has or had stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. The institution of Dr. Schwedt has received research support from AbbVie. The institution of Dr. Schwedt has received research support from Flinn Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Vincenzo Silani, MD, FAAN	Dr. Silani has nothing to disclose.
Paola Caroppo	Paola Caroppo has nothing to disclose.
Paola Valsasina	Paola Valsasina has nothing to disclose.
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
	No disclosure on file
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Nilufer Taner, MD, PhD, FAAN	The institution of Dr. Taner has received research support from NIH.
Netta Levin, MD, PhD	Dr. Levin has nothing to disclose.
Abu Nasar	No disclosure on file
Susan Gauthier, DO	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
Charles R. Guttmann	Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Stephen B. Shrewsbury, MD	Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
M. Antonietta Volonte, MD	Dr. Volonte has nothing to disclose.
Adi Vaknin-Dembinsky, MD	Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for neopharm group. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for medisone . Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for alexion.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Robert Spinner	No disclosure on file
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Aninda Acharya, MD	Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Acharya has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Tony Wu, MD, PhD	Dr. Wu has nothing to disclose.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Alex Rovira	Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
Stephen Weigand	Stephen Weigand has nothing to disclose.
Mathew J. Reeves, PhD, BVSc	Mathew J. Reeves, PhD, BVSc has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Ashfaq Shuaib, MD	Dr. Shuaib has nothing to disclose.
Peter J. Dyck, MD, FAAN	Dr. Dyck has nothing to disclose.
Jennifer Whitwell, PhD	The institution of Dr. Whitwell has received research support from NIH.
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Leo Wolansky, MD	The institution of Dr. Wolansky has received research support from Guerbet.
Howard W. Sander, MD, FAAN	Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Peter Hedera, MD	Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
Elinor Ben-Menachem, MD, FAAN	Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Susan M. Bowyer, PhD	Dr. Bowyer has nothing to disclose.
Minerva Carrasquillo	The institution of Minerva Carrasquillo has received research support from NIA. The institution of Minerva Carrasquillo has received research support from Carl Angus DeSantis Foundation. The institution of Minerva Carrasquillo has received research support from Florida Department of Health. Minerva Carrasquillo has received personal compensation in the range of $500-$4,999 for serving as a Reviewer for Study Section with NIH.
Karla P. Figueroa	Ms. Figueroa has nothing to disclose.
Francesca Bagnato, MD	Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Dawn O. Kleindorfer, MD, FAAN	Dr. Kleindorfer has nothing to disclose.
Pooja Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silvercreek. The institution of Dr. Khatri has received research support from NIH/NINDS. The institution of Dr. Khatri has received research support from AHA. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Kathleen Alwell	No disclosure on file
Matthew L. Flaherty, MD	Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care.
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Seth A. Smith, PhD	Dr. Smith has nothing to disclose.
David G. Vossler, MD, FAAN	Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. Dr. Vossler has received publishing royalties from a publication relating to health care.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Cornelia Laule, PhD	The institution of Dr. Laule has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Laule has received research support from Natural Sciences and Engineering Research Council of Canada (NSERC). The institution of Dr. Laule has received research support from International Collaboration on Repair Discoveries (ICORD).
Rana R. Said, MD, FAAN	Dr. Said has nothing to disclose.
Dinesh Kumar	Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for pfizer. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
DaiWai Olson	The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Chiesi.
Joseph P. Hanna, MD	Dr. Hanna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MCG part of Hearst Health Network. Dr. Hanna has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney General State of Ohio.
Sameer Chhibber, MD	The institution of Dr. Chhibber has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Chhibber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Nutan Sharma, MD, PhD, FAAN	Dr. Sharma has nothing to disclose.
Michael H. Lev, MD	Michael H. Lev, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda, Roche-Genetech. The institution of Michael H. Lev, MD has received research support from GE. Michael H. Lev, MD has received publishing royalties from a publication relating to health care.
Walter N. Kernan, MD	Dr. Kernan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms.
David J. Nicholl, PhD, FRCP	Dr. Nicholl has nothing to disclose.
David A. Wolk, MD, FAAN	Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care.
Jaime Imitola, MD, FAAN	The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Alejandro R. Marfil-Rivera, MD	Dr. Marfil-Rivera has nothing to disclose.
Tamara M. Pringsheim, MD, FAAN	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Juan F. Gongora Rivera, MD, MD, MSc, PhD	Dr. Gongora Rivera has nothing to disclose.
Wendyl J. D'Souza, MD, MBChB	Dr. D'Souza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova, Eisai, UCB, Tilray. Dr. D'Souza has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB Pharma, Eisai Pharmaceutical. Dr. D'Souza has stock in Epiminder. The institution of Dr. D'Souza has received research support from UCB Pharma. The institution of Dr. D'Souza has received research support from Eisai Pharmaceutical.
Jeremiah M. Scharf, MD, PhD	The institution of Dr. Scharf has received research support from the TLC Foundation for Body-Focused Repetitive Behaviors. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Speaker for a TAA/CDC Family Day Symposium with the Tourette Association of America. Dr. Scharf has a non-compensated relationship as a Scientific Advisory Board Member with the Tourette Association of America that is relevant to AAN interests or activities.
Roland G. Henry, PhD	Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Suparna R. Krishnaiengar, MD	Dr. Krishnaiengar has nothing to disclose.
Daniel Antoniello, MD	Dr. Antoniello has nothing to disclose.
Cristina Granziera, MD, PhD	The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen.
Mary Haverbusch	No disclosure on file
Wei Liu, MD	Dr. Liu has nothing to disclose.
Opeolu Adeoye	No disclosure on file
Esra Battaloglu	Esra Battaloglu has nothing to disclose.
JaNean Engelstad	JaNean Engelstad has nothing to disclose.
Justin Thorson, MD	Dr. Thorson has nothing to disclose.
Joachim Krauss	No disclosure on file
Mai Yamakawa, MD	Dr. Yamakawa has nothing to disclose.
Aurelia Poujois	Aurelia Poujois has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphalan. Aurelia Poujois has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Univar.
Bernhard Steinhoff	Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $0-$499 for serving as a Consultant for B.Braun Melsungen. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precisis. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Bernhard Steinhoff has received research support from UCB. The institution of Bernhard Steinhoff has received research support from Eisai. The institution of Bernhard Steinhoff has received research support from SK LIfe Science.
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
Marcia E. Morita-Sherman, MD	An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Richard L. Barbano, MD, PhD, FAAN	Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Barbano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Revance. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
Alan Z. Segal, MD, FAAN	Dr. Segal has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms. Dr. Segal has received publishing royalties from a publication relating to health care.
W. C. LaFrance, Jr., MD, MPH, FAAN	Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Wouter Schievink, MD	Dr. Schievink has nothing to disclose.
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Nancy M. Nealon, MD	Dr. Nealon has nothing to disclose.
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Jason S. Mackey, MD	Dr. Mackey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for legal firms. The institution of Dr. Mackey has received research support from PCORI.
Daniel Pastula, MD, MHS, FAAN	Dr. Pastula has nothing to disclose.
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Anna Czlonkowska, MD	Dr. Czlonkowska has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN	Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Teneille Gofton, MD	The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Jiangyong Min, MD	Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation .
Alberto Albanese, MD	Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen pharma. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz pharms. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Publishing Group. Dr. Albanese has a non-compensated relationship as a President with International Association on Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Elisabeth Wilde	Elisabeth Wilde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuropsychology. The institution of Elisabeth Wilde has received research support from CDMRP/DoD. The institution of Elisabeth Wilde has received research support from VA. The institution of Elisabeth Wilde has received research support from NIH. The institution of Elisabeth Wilde has received research support from Cohen Veteran Biosciences.
Bruce D. Trapp, PhD	Dr. Trapp has received personal compensation for serving as an employee of Renovo Neural Inc.. The institution of Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therini Bio, Inc.. Dr. Trapp has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Trapp has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm Therapeutics. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kantonsspital Aarau AG. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for triMS.online. The institution of Dr. Trapp has received research support from Genzyme Corporation. The institution of Dr. Trapp has received research support from ALS Association. The institution of Dr. Trapp has received research support from National Institute of Neurological Disorders and Stroke.
Laura Airas, MD, PhD	Dr. Airas has nothing to disclose.
Amir M. Arain, MD, FAAN	Dr. Arain has nothing to disclose.
Danny Bega, MD	Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SOM. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
John F. Foley, MD, FAAN	The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Daniel M. Harrison, MD, FAAN	Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Gyanendra Kumar, MD, FAAN	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Caterina Mainero, MD, PhD	The institution of Dr. Mainero has received research support from Genentech.
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Babak Navi, MD	Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Yoshinori Nishimoto	Yoshinori Nishimoto has received research support from Japan Society for the Promotion of Science.
Virginia A. Pujol Lereis, MD	Dr. Pujol Lereis has nothing to disclose.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Parthasarathy Thirumala, MD, FAAN	The institution of Dr. Thirumala has received research support from University of Pittsburgh.
Arun Venkatesan, MD, PhD	Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Jiwon Oh, MD, FAAN	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Kim I. Bishop, PhD	Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for zogenix. Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medtronic. Dr. Bishop has stock in zogenix.
Michel C. Shamy, MD	Dr. Shamy has nothing to disclose.
Shibeshih Belachew, MD	Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Stefan Bittner	Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Massimiliano Calabrese	Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. The institution of Massimiliano Calabrese has received research support from Roche.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Lori Chibnik	No disclosure on file
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Khosro Farhad, MD, FAAN	Dr. Farhad has nothing to disclose.
Simona Ferioli, MD	Dr. Ferioli has nothing to disclose.
Charles Maitland	No disclosure on file
Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Jonathan C. Edwards, MD	Dr. Edwards has received intellectual property interests from a discovery or technology relating to health care.
Jeff M. Bronstein, MD, PhD	Dr. Bronstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. The institution of Dr. Bronstein has received research support from NIH. The institution of Dr. Bronstein has received research support from Levine Foundation.
Pedro Rosa Neto, MD, PhD	Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
William Rooney, PhD	Dr. Rooney has nothing to disclose.
Joao A. Gomes, MD	Dr. Gomes has nothing to disclose.
Jan N. Lycke, MD	Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GeNeuro. The institution of Dr. Lycke has received research support from Sanofi.
David Pitt, MD	Dr. Pitt has nothing to disclose.
Brandon P. Foreman, MD	Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell, Inc. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Consultant for Natus Medical Incorporated. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Consultant for Immedica, Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sophysa, Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma Inc.. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Reminger Co, LPA. The institution of Dr. Foreman has received research support from DOD/AMRMC. The institution of Dr. Foreman has received research support from Biogen, Inc.. The institution of Dr. Foreman has received research support from DOD/AFRL. The institution of Dr. Foreman has received research support from NSF SCH:INT. The institution of Dr. Foreman has received research support from NIH/NIBIB. The institution of Dr. Foreman has received research support from DOD/JWMRP. The institution of Dr. Foreman has received research support from Marinus Pharmaceuticals. The institution of Dr. Foreman has received research support from PCORI. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Natus Medical Incorporated. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Ceribell, Inc.. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Peer-to-peer program honoraria with Marinus Pharmaceuticals.
Christopher Hemond, MD	The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Felipe De Los Rios La Rosa, MD	Dr. De Los Rios La Rosa has nothing to disclose.
John Probasco, MD, FAAN	Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech.
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic Education Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
James E. Siegler III, MD	Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Francesca Caso, MD	Dr. Caso has nothing to disclose.
Jennifer A. Vermilion, MD	The institution of Dr. Vermilion has received research support from Centers for Disease Control. The institution of Dr. Vermilion has received research support from Emalex Biosciences. The institution of Dr. Vermilion has received research support from Biomarin. The institution of Dr. Vermilion has received research support from Neurogene, Inc. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Tourette Association of America. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Centers for Disease Control and Prevention and American Academy of Pediatrics.
Tony Daniels	Tony Daniels has received personal compensation for serving as an employee of UCB. Tony Daniels has stock in UCB.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Antonio Scalfari, MD	Dr. Scalfari has nothing to disclose.
Russell T. Shinohara	Mr. Shinohara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. The institution of Mr. Shinohara has received research support from National Institutes of Health. The institution of Mr. Shinohara has received research support from National Multiple Sclerosis Society.
Eugen Trinka	Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Vicente Villanueva	Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Paladin. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceutical.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
David J. Houghton, MD	Dr. Houghton has nothing to disclose.
Shaheen E. Lakhan, MD, PhD, MEd, FAAN	Dr. Lakhan has received personal compensation for serving as an employee of Zogenix, Fern Health, Thriveworks, The Learning Corp, TriNet, Click Therapeutics. Dr. Lakhan has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Shaheen Lakhan, MD, PhD, LLC. Dr. Lakhan has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, Fern Health, Lin Health. Dr. Lakhan has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Click Therapeutics, SpineThera. Dr. Lakhan has stock in Zogenix, NeuroSport, Click Therapeutics, SpineThera.
Michael D. Fox, MD, PhD	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Renzo Guerrini	Renzo Guerrini has nothing to disclose.
Nawaz Hack, MD	Dr. Hack has nothing to disclose.
Jimmy Holder, MD	Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical.
Sharyl R. Martini, MD, PhD	Dr. Martini has nothing to disclose.
Stella L. Ngo, PhD	Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc.. Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc..
Vasileios-Arsenios Lioutas, MD	Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association.
Nils Petersen, MD, FAAN	The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH.
Christina Azevedo, MD, FAAN	Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Smith, Henning & Berman LLP. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Carol Mathews	The institution of Carol Mathews has received research support from NIH.
Daniel DiCapua, MD, FAAN	Dr. DiCapua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. DiCapua has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Markus Reuber	No disclosure on file
Kunal V. Desai, MD	Dr. Desai has nothing to disclose.
Channa A. Hewamadduma, MBBS, PhD, FRCP, MSc	Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE).
Jennifer A. O'Malley, MD, PhD	Dr. O'Malley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for PTC Therapeutics. Dr. O'Malley has stock in Doximity. An immediate family member of Dr. O'Malley has stock in Amazon.
Joseph Duffy	The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Matthew E. Fink, MD, FAAN	Dr. Fink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Relias LLC.
David Cachia, MD	Dr. Cachia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RedHill Biopharma Ltd. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Global LLC. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dedham Group. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Massachusetts Neurological Society.
Rachel Forman, MD	Dr. Forman has nothing to disclose.
Sarah E. Berini, MD	Dr. Berini has nothing to disclose.
Martina Absinta, MD	Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. The institution of Dr. Absinta has received research support from International MS Alliance. The institution of Dr. Absinta has received research support from FRRB Early Career Award. The institution of Dr. Absinta has received research support from Cariplo Foundation.
Kelly G. Knupp, MD	The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research.
Derek Debicki, MD	Dr. Debicki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Canada Inc.. The institution of Dr. Debicki has received research support from Academic Medical Association of Southwestern Ontario. The institution of Dr. Debicki has received research support from Western BrainScan. The institution of Dr. Debicki has received research support from Lawson Research. The institution of Dr. Debicki has received research support from Canadian Institutes of Health Research.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Mehmood Rashid, MD	Dr. Rashid has nothing to disclose.
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to AAN interests or activities.
Michele Cavallari, MD	The institution of Dr. Cavallari has received research support from BrightFocus Foundation. The institution of Dr. Cavallari has received research support from Brigham Research Institute. The institution of Dr. Cavallari has received research support from Department of Radiology at Brigham and Women's Hospital. The institution of Dr. Cavallari has received research support from Hebrew SeniorLife Rehabilitation Center. Dr. Cavallari has received intellectual property interests from a discovery or technology relating to health care.
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Vijayakumar Javalkar, MD, MCh, FAAN	Dr. Javalkar has nothing to disclose.
Moshe A. Mizrahi, MD, FAAN	Dr. Mizrahi has nothing to disclose.
Lauren H. Sansing, MD	Dr. Sansing has nothing to disclose.
Alberto B. Vasquez, MD	No disclosure on file
Winona W. Tse, MD	Dr. Tse has nothing to disclose.
Halina White, MD MA BA	Dr. White has nothing to disclose.
Bhooma R. Aravamuthan, MD, DPhil, FCNS, FAAN	The institution of Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Aravamuthan has received research support from Child Neurology Foundation. The institution of Dr. Aravamuthan has received research support from American Board of Psychiatry and Neurology. The institution of Dr. Aravamuthan has received research support from Centers for Disease Control. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Marisela E. Dy-Hollins, MD, MSCR, FAAN	The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
Joel N. Phillips, DO, FAAN	Dr. Phillips has nothing to disclose.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Michael J. Star, MD	Dr. Star has nothing to disclose.
Anza B. Memon, MD, FAAN	Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened. Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic . The institution of Dr. Memon has received research support from Genentech. The institution of Dr. Memon has received research support from TG Therapeutics.
Fernando Maestu	Fernando Maestu has nothing to disclose.
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Roy has or had stock in Cabaletta bio. .Dr. Roy has or had stock in Pfizer.Dr. Roy has or had stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Jessica E. Rexach, MD, PhD	Dr. Rexach has nothing to disclose.
Michelle P. Lin, CRC	Dr. Lin has nothing to disclose.
Ashhar Ali, DO, FAAN	Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Rick Gill, MD	Dr. Gill has nothing to disclose.
Charlene J. Ong, MD	Dr. Ong has nothing to disclose.
Eliza C. Miller, MD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Adrian Owen	Adrian Owen has stock in Creyos Inc.
Ankit Pahwa	Ankit Pahwa has nothing to disclose.
Brian Kopell	No disclosure on file
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.
Eva A. Mistry	No disclosure on file
Helena Gama	Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A..
Nicholas Thompson	The institution of Nicholas Thompson has received research support from EMD Serono.
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Richard Reilly, PhD	Dr. Reilly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for La Caixa Foundation. Dr. Reilly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Caixa Foundation, Barcelona, Spain. The institution of Dr. Reilly has received research support from Enterprise Ireland. The institution of Dr. Reilly has received research support from Science Foundation Ireland. The institution of Dr. Reilly has received research support from Health Research Board.
Thanh Nguyen	No disclosure on file
Roland Dominic Jamora	Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Z P. L'Erario, MD, LMSW	Dr. L'Erario has received publishing royalties from a publication relating to health care.
Angela Y. Peters, MD	The institution of Dr. Peters has received research support from NIH.
Sameer Sharma, MD, MBBS	Dr. Sharma has nothing to disclose.
Gerard A. Gioia, MD	Dr. Gioia has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Pharma Consultancy. Dr. Gioia has received publishing royalties from a publication relating to health care.
Richard Libman, MD, FAAN	Dr. Libman has nothing to disclose.
Mahnaz Asgharnejad, PharmD	Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Richard Stark, MBBS, FRACP	Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Stark has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Stark has stock in CSL. Dr. Stark has stock in Multiple ASX listed (non-medical) companies. Dr. Stark has received personal compensation in the range of $10,000-$49,999 for serving as a TCMC Committee chair with AMA Victoria.
Roshini Jain	Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Adam S. Jasne, MD	Dr. Jasne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Scott Siegert	Mr. Siegert has received personal compensation for serving as an employee of Neurocrine Biosciences. Mr. Siegert has stock in Neurocrine Biosciences.
Neal S. Parikh, MD	Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has or had stock in Alnylam Pharmaceuticals.
Ulrike Kaunzner, MD	Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Tamara Hoyt	Ms. Hoyt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
Christian J. Camargo, MD	Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Health. The institution of Dr. Camargo has received research support from American Academy of Neurology.
Atul T. Patel	Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
Cris M. Ida	Cris M. Ida, 4790 has nothing to disclose.
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Mindl M. Weingarten, PharmD	Dr. Weingarten has received personal compensation for serving as an employee of SK Life Science.
Mariel Pullman, MD	The institution of Dr. Pullman has received research support from Empire Clinical Research Investigator Program.
Annemie Ribbens	Annemie Ribbens has received personal compensation for serving as an employee of icometrix. Annemie Ribbens has stock in icometrix. Annemie Ribbens has received intellectual property interests from a discovery or technology relating to health care.
Abbas Kharal, MD	Dr. Kharal has nothing to disclose.
Naomi Lubarr, MD	Dr. Lubarr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for applied therapeutics.
Avinash Chandra, MD	Dr. Chandra has nothing to disclose.
Nicholas A. Frost, MD, PhD	The institution of Dr. Frost has received research support from Simons Foundation. The institution of Dr. Frost has received research support from National Institutes of Health.
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Ava L. Liberman, MD	Dr. Liberman has nothing to disclose.
Jenny Wilson, MD	The institution of Dr. Wilson has received research support from Neurocrine Biosciences. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Rite question reviewer with AAN.
Katherine E. Leaver, MD	Dr. Leaver has nothing to disclose.
Jennifer Harris, MD	Dr. Harris has nothing to disclose.
Jennifer V. Robblee, MD	Dr. Robblee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix. An immediate family member of Dr. Robblee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Scottsdale Providence. The institution of Dr. Robblee has received research support from Eli Lilly. The institution of Dr. Robblee has received research support from AbbVie. The institution of Dr. Robblee has received research support from Barrow Neurological Institute. Dr. Robblee has received publishing royalties from a publication relating to health care. Dr. Robblee has received publishing royalties from a publication relating to health care.
Ravi Garg, MD	Dr. Garg has nothing to disclose.
Nadeem I. Khan, MD	Dr. Khan has nothing to disclose.
Sabreena J. Slavin, MD	Dr. Slavin has nothing to disclose.
Nolan Campbell	Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
Jesse Thon, MD	An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Angelene Christensen	Ms. Christensen has a non-compensated relationship as a project manager with InterPro Bioscience that is relevant to AAN interests or activities.
David Cantu, PhD	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Sebastiano Galantucci	Mr. Galantucci has nothing to disclose.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Carlos Cevallos, MD	Dr. Cevallos has nothing to disclose.
Heather Clark	The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care.
Hugo Cuellar-Saenz	No disclosure on file
Lilly Fagatele	Ms. fagatele has nothing to disclose.
Marcus Sucksdorff, MD	Dr. Sucksdorff has nothing to disclose.
Saad A. Mir, MD	Dr. Mir has nothing to disclose.
Catherine D. Chong, PhD, FAAN	Dr. Chong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCOP.
J. Helen Cross	Dr. Cross has nothing to disclose.
Leana Doherty, MD	Dr. Doherty has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM.
Edrich J. Rodrigues, MBBChB	The institution of Dr. Rodrigues has received research support from Australian Brain Foundation.
Davide Martino, MD, PhD	Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Ning Su, MD	Dr. Su has nothing to disclose.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Sami Alkasab, MD	Dr. Alkasab has nothing to disclose.
Nara Michaelson, MD	The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
Tamra I. Ranasinghe, MD	Dr. Ranasinghe has nothing to disclose.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Arie Gafson, MD, PhD	Dr. Gafson has stock in Biogen.
Roman Rubio	Roman Rubio has received personal compensation for serving as an employee of Revance.
Samantha Roman, MD	Dr. Roman has nothing to disclose.
Xenos Mason, MD	Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott Labs. Dr. Mason has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen .
Ylec M. Cardenas Castillo, MD	Dr. Cardenas Castillo has nothing to disclose.
Maria G. Martucci, MD	Dr. Martucci has nothing to disclose.
Adrian I. Espiritu, MD	Dr. Espiritu has nothing to disclose.
Tracy J. Koehler	Tracy J. Koehler has nothing to disclose.
Gina Dumkrieger, PhD	Gina Dumkrieger has received personal compensation for serving as an employee of Mayo Clinic. The institution of Gina Dumkrieger has received research support from NIH. The institution of Gina Dumkrieger has received research support from DOD. The institution of Gina Dumkrieger has received research support from AMGEN.
Camilo Bermudez, MD, PhD	Dr. Bermudez has nothing to disclose.
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Alexandra Boubour	Ms. Boubour has received research support from The Fulbright Program.
Feng Tian	No disclosure on file
Fedor Panov	Fedor Panov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. Fedor Panov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for zimmer biomet.
Adam Strzelczyk	Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bicodex. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Desitin. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UNEEG.
Christopher A. Brown, MD, PhD	The institution of Dr. Brown has received research support from National Institute of Health.
Ayse Candayan	Ayse Candayan has nothing to disclose.
Elizabeth Fisher	Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Javier Salas-Puig	No disclosure on file
Fei Han	Fei Han has nothing to disclose.
Jun Ni	Jun Ni has nothing to disclose.
Ming Yao	Ming Yao has nothing to disclose.
Pratit D. Patel, MD	Dr. Patel has nothing to disclose.
Anne M. Morse, DO	Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Hayes solicitors. Dr. Morse has received publishing royalties from a publication relating to health care. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with DAMM Good Sleep, LLC.
Jane Khalife, MD	Dr. Khalife has nothing to disclose.
Catherine Hassett, MD	Dr. Hassett has nothing to disclose.
Vijay K. Ramanan, MD, PhD, FAAN	The institution of Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daridorexant trial for AD prevention (funded by Weston Family Foundation). The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. The institution of Dr. Ramanan has received research support from Expert Perspectives in Medicine. The institution of Dr. Ramanan has received research support from ADLM (webinar supported by educational grant from Roche). The institution of Dr. Ramanan has received research support from American College of Radiology. Dr. Ramanan has received research support from Clinical Care Options. Dr. Ramanan has received research support from PeerView Institute (webinar supported by educational grant from Lilly). Dr. Ramanan has received personal compensation in the range of $5,000-$9,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Anthony M. Bradshaw, MD	Dr. Bradshaw has nothing to disclose.
Balakrishnan Ramasamy, MD, MBBS	Dr. Ramasamy has nothing to disclose.
Jason S. Gill, MD, PhD	Dr. Gill has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Elite Medical Experts. The institution of Dr. Gill has received research support from NIH-NINDS.
Malgorzata Miller, MD	The institution of Dr. Miller has received research support from NIH StrokeNet VERIFY trial.
Ranier G. Reyes, MD	Dr. Reyes has nothing to disclose.
Yasmin Aghajan, MD	Dr. Aghajan has nothing to disclose.
Shahin Khayambashi, MD	Dr. Khayambashi has nothing to disclose.
Emily Dennis, PhD	The institution of Ms. Dennis has received research support from NIH.
Andrew Cutler	Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for AbbVie. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Alkermes. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Axsome. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Boehringer Ingelheim. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Myers Squibb. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Delpor. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for 4M Therapeutics. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for J&J. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for MapLight Therapeutics. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Neumora. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurocrine. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Noven. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Relmada. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Supernus. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Tris Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for COMPASS Pathways. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Freedom Biosciences. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AbbVie. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkermes. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Axsome. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for J&J. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Neurocrine. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Noven. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Otsuka. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Supernus. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Tris Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Vanda Pharmaceuticals. Andrew Cutler has stock in 4M Therapeutics. Andrew Cutler has stock in Relmada.
Stacie L. Demel, DO	Dr. Demel has nothing to disclose.
Adeel Zubair, MD	Dr. Zubair has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The MedNet.
Jose Manuel Garcia Dominguez	Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Colm Elliott	Colm Elliott has received personal compensation for serving as an employee of NeuroRx Research.
Roberto P. Ortega, MD	No disclosure on file
Elisheva R. Coleman, MD	Dr. Coleman has nothing to disclose.
Alfredo Quinones-Hinojosa	Alfredo Quinones-Hinojosa has nothing to disclose.
Kevin C. O'Connor, PhD	Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Immunovant. Kevin C. O'Connor, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Kevin C. O'Connor, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurocrine. Kevin C. O'Connor, PhD has stock in Cabaletta. The institution of Kevin C. O'Connor, PhD has received research support from Seismic. The institution of Kevin C. O'Connor, PhD has received research support from Argenx. Kevin C. O'Connor, PhD has received intellectual property interests from a discovery or technology relating to health care.
Lilly Chen	Lilly Chen has received personal compensation for serving as an employee of Boston Scientific .
Daniel Garbin Di Luca, MD	Dr. Garbin Di Luca has nothing to disclose.
Sami M. Aboumatar, MD	Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science, Inc.. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
Melinda S. Martin, PhD	Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has or had stock in UCB.
Michelle D. DeJesus Brazitis, MD	Dr. DeJesus Brazitis has nothing to disclose.
Richa Sharma, MD	Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Virginia Baker, MD	Dr. Baker has nothing to disclose.
Cedric Laloyaux, PhD	Dr. Laloyaux has received personal compensation for serving as an employee of UCB.
Nabil Wees, MD	Dr. Wees has nothing to disclose.
Sutapa Ray, PhD	Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Stephanie Lyden, MD	Dr. Lyden has nothing to disclose.
Sydni Cole, MD	Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Arvin Parvathaneni, MD	Dr. Parvathaneni has nothing to disclose.
Tikku George, MD	Dr. George has nothing to disclose.
Andre Granger, MD, MBA	Dr. Granger has nothing to disclose.
Louis Ferrari	Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Melih Tutuncu, MD	Dr. Tutuncu has nothing to disclose.
Sudipto Dolui, PhD	Dr. Dolui has nothing to disclose.
Arman Cakar	Arman Cakar has nothing to disclose.
Veronica Castelnovo, MSc	Dr. Castelnovo has nothing to disclose.
Bade Gulec	Bade Gulec has nothing to disclose.
Darshan Mehta	Darshan Mehta has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. .
Kyle Walsh	No disclosure on file
Michela Leocadi, MSc	Dr. Leocadi has nothing to disclose.
Iryna Leunikava	No disclosure on file
Yuehui Hong	Ms. Hong has nothing to disclose.
Felix Rosenow	No disclosure on file
Maria Agustina Ruiz Yanzi, MD	Dr. Ruiz Yanzi has nothing to disclose.
Mario E. Ricciardi, Sr., MD	Dr. Ricciardi has nothing to disclose.
Marjo Nylund	Ms. Nylund has received research support from The Finnish MS Foundation. Ms. Nylund has received research support from Maire Taponen Foundation. Ms. Nylund has received research support from The Finnish Cultural Foundation.
Nikolai Gil D. Reyes, MD	Dr. Reyes has nothing to disclose.
Camilla Cividini, MSc	Ms. Cividini has nothing to disclose.
Luisa A. Diaz-Arias, MD	Dr. Diaz-Arias has nothing to disclose.
Maria A. Garcia-Dominguez, MD	Dr. Garcia-Dominguez has received personal compensation for serving as an employee of Genentech.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Rose Gelineau-Morel, MD	Dr. Gelineau-Morel has nothing to disclose.
Elizabeth Matthews, MD	Dr. Matthews has nothing to disclose.
Ildebrando H. Appollonio, MD	Dr. Appollonio has nothing to disclose.
Gregory N. Beatch, PhD	Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Erik Middlebrooks	Erik Middlebrooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Corp. Erik Middlebrooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Siemens Healthineers. Erik Middlebrooks has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Neuroradiology.
Madeleine Klein, BS	The institution of an immediate family member of Madeleine Klein has received research support from NIH.
Joshua Battley, MD	Dr. Battley has nothing to disclose.
Jyotika Singh	Ms. Singh has nothing to disclose.
Kendra K. Davis	Ms. Davis has nothing to disclose.
Melanie Marcille	Ms. Marcille has nothing to disclose.
Rene Utianski	Rene Utianski has nothing to disclose.
Robert Joseph C. Sarmiento, MD	Dr. Sarmiento has nothing to disclose.
Alexander Sandweiss, MD, PhD	Dr. Sandweiss has nothing to disclose.
Rebecca J. Levy, MD	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SRB Hawaii Law LLC. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wisner Baum LLP. The institution of Dr. Levy has received research support from CNCDP-K12. The institution of Dr. Levy has received research support from NINDS.
Sviatoslav Redko, MD	Dr. Redko has nothing to disclose.
Ayush Chandra, MBBS	Mr. Chandra has nothing to disclose.
Tyler A. Gumpel	Tyler Gumpel has nothing to disclose.
Zarmina Mufti, MD	Dr. Mufti has nothing to disclose.
Anne-Liv Schulz	No disclosure on file
John R. Mills, MD, PhD	The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Sung Chul Lim	Sung Chul Lim has nothing to disclose.
Mar Tintoré, MD, PhD	The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela bio. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel and UCB Biopharma. Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal: Experimental, Translational and Clinical. The institution of Mar Tintoré, MD, PhD has received research support from Fundació La Marató de TV3. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III.
Shahar Shelly, MD	Dr. Shelly has or had stock in Remepy.
Shameer Rafee, MBBS	Dr. Rafee has nothing to disclose.
Takamichi Yamamoto, MD, PhD, FAES	Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Daiichi-Sankyo.
Carmen Vizzino	No disclosure on file
Rahul Chandra, MD	Dr. Chandra has nothing to disclose.
Nadia Khalil, MD	Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a Resident and Fellow Council Member with American Association of Neuromuscular & Electrodiagnostic Medicine. Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a MS Mentorship Forum Participant with Foundation of the Consortium of Multiple Sclerosis Centers.
Eduardo Dunayevich, MD	Eduardo Dunayevich has received personal compensation for serving as an employee of Neurocrine Biosciences. Eduardo Dunayevich has stock in Neurocrine Biosciences.
Andrew Dugue, MD	Dr. Dugue has nothing to disclose.
Ashley Raedy, MD	Dr. Raedy has nothing to disclose.
Sarah S. Zaheer, MD	Dr. Zaheer has nothing to disclose.
Alma Ghirelli	Ms. Ghirelli has nothing to disclose.
Eoghan Donlon, MBBS	Dr. Donlon has nothing to disclose.
Mahesh Kate, MD	Dr. Kate has nothing to disclose.
Alicia M. Zukas, MD	Dr. Zukas has nothing to disclose.
Christopher Hahn, MD	Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylim.
Brian Pfister	Dr. Pfister has received personal compensation for serving as an employee of Praxis Precisions Medicines. Dr. Pfister has stock in Praxis Precision Medicines.
Max M. Klein, PhD	The institution of Max M. Klein, PhD has received research support from NIH.
Bertrand P. Tseng, MD, PhD	Dr. Tseng has nothing to disclose.
Janneke Van Wingerden	Janneke Van Wingerden has received personal compensation for serving as an employee of Sanofi Genzyme.
Cortnee Roman, NP, DAAN	Ms. Roman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genzyme. Ms. Roman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Ms. Roman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myer Squibb/Celgene.
Shan Siddiqi, MD	Dr. Siddiqi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Magnus Medical. Dr. Siddiqi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brainsway Ltd. Dr. Siddiqi has stock in Brainsway Ltd. Dr. Siddiqi has stock in Magnus Medical. Dr. Siddiqi has received intellectual property interests from a discovery or technology relating to health care.
Chandra Sekhar Mannyam, MBBS	Dr. Mannyam has nothing to disclose.
Daniel P. Bradley	Daniel Bradley has nothing to disclose.
Junaid Ansari, MD	Dr. Ansari has nothing to disclose.
Jocelyn B. Lorenzo, MD	Dr. Lorenzo has nothing to disclose.
Jenny P. Tsai, MD	Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Q'Apel. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Tsai has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of NeuroInterventional Surgery.
Meesha Trivedi	The institution of Ms. Trivedi has received research support from American Academy of Neurology.
Eric Jen	Eric Jen has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Nha Trang Thu Pham	Nha Trang Thu Pham has received personal compensation for serving as an employee of Mayo Clinic.
Marissa M. Castillo	Ms. Castillo has nothing to disclose.
Mahouba Frih	MAHBOUBA FRIH has nothing to disclose.
Yongsheng Chen, PhD	Dr. Chen has nothing to disclose.
Bastien C. Caba	Mr. Caba has received personal compensation for serving as an employee of Therapanacea. Mr. Caba has received personal compensation for serving as an employee of Biogen. Mr. Caba has received personal compensation in the range of $50,000-$99,999 for serving as a Research Engineer with Therapanacea. Mr. Caba has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist II, ML/AI with Biogen.
Domenico Vitarella	No disclosure on file
Ali Mohajer, PhD	Dr. Mohajer has received personal compensation for serving as an employee of Qral Group, LLC.
Todd Gross	Todd Gross has received personal compensation for serving as an employee of Revance Therapeutics Inc. Todd Gross has stock in Revance Therapeutics Inc.
Prashant Dongre, MD, MBBS	Dr. Dongre has received personal compensation for serving as an employee of UCB Inc. Dr. Dongre has stock in UCB Inc.
Lucio Tremolizzo	Lucio Tremolizzo has nothing to disclose.
Gregory S. Connor, MD	The institution of Dr. Connor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Life Sciences. The institution of Dr. Connor has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences.
Jaclyn Martindale, DO, FAAN	Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Young-Min Kim, MD	Dr. Kim has nothing to disclose.
Omar Samad, PhD	Dr. Samad has received personal compensation for serving as an employee of Eisai.
Robert Vann, PhD	Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
Melissa Mariscal, MD	Dr. Mariscal has nothing to disclose.
Isaiah Kletenik, MD	The institution of Dr. Kletenik has received research support from NIH.
Anisha Garg, MD	Dr. Garg has nothing to disclose.
Bahadar S. Srichawla, DO, MS	Dr. Srichawla has nothing to disclose.
Evan Kolesnick, DO	Mr. Kolesnick has nothing to disclose.
Matthew Hart, MD	Dr. Hart has nothing to disclose.
Philip M. McCarthy, DO	Dr. McCarthy has nothing to disclose.
Kenneth Dalton III, MD	Dr. Dalton has nothing to disclose.
Victoria Rice, DO	Dr. Rice has nothing to disclose.
Rachel E. Glasser, MD	Dr. Triay has nothing to disclose.
Linda Harris, MPH	Ms. Harris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. Harris has received stock or an ownership interest from Biohaven Pharmaceuticals.
Amir Neshatfar, MD	Dr. Neshatfar has nothing to disclose.
Maithreyi Chappidi, MD	Dr. Chappidi has nothing to disclose.
Alyssa M. Smith, MD	Dr. Smith has nothing to disclose.
Kimberly O'Neill, MD	Dr. O'Neill has nothing to disclose.
Purva Choudhari, MD	Dr. Choudhari has nothing to disclose.
Sanem P. Uysal, MD	Dr. Uysal has nothing to disclose.
Xue Yang, MD, PhD	Dr. Yang has nothing to disclose.
Sara Prioni	Sara Prioni has nothing to disclose.
Christopher J. Fitzpatrick, PhD	Dr. Fitzpatrick has received personal compensation for serving as an employee of Impel Pharmaceuticals.
Phoebe Jiang, PhD	Dr. Jiang has received personal compensation for serving as an employee of Biogen. Dr. Jiang has stock in Biogen.
Kathleen Miao	Ms. Miao has nothing to disclose.
Anastasia Railean, MD	Dr. Railean has nothing to disclose.
Julia Miao	Miss Miao has nothing to disclose.
Sarah Shapiro	Miss Shapiro has nothing to disclose.
Prabandh R. Buchhanolla, MBBS	Dr. Buchhanolla has nothing to disclose.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Nicolò Tedone	Nicolò Tedone has nothing to disclose.
Matteo Azzimonti	No disclosure on file
Karnig Kazazian, PhD	Dr. Kazazian has nothing to disclose.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Sean Stern	Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Florin Floricel	No disclosure on file
Pannathat Soontrapa, MD	The institution of Dr. Soontrapa has received research support from Argenx.
Eero Polvinen	Mr. Polvinen has nothing to disclose.
Neha Atulkumar Singh, PhD	Dr. Singh has nothing to disclose.
Oscar E. Garat, MD	Mr. Garat has nothing to disclose.
Veronica Sendersky	No disclosure on file
Hossam Youssef, MD	Mr. Youssef has nothing to disclose.
Michelle Miranda	No disclosure on file
Michelle Murphy, PhD	Dr. Murphy has nothing to disclose.
Barbara Basil, MD	Dr. Basil has nothing to disclose.
Angela Russell, MD	Dr. Russell has nothing to disclose.
Ronak U. Trivedi	Mr. Trivedi has nothing to disclose.
Muhammed Ors	Mr. Ors has nothing to disclose.
Samet Cam	No disclosure on file
Laura Couvreur, MD	Dr. Couvreur has received personal compensation in the range of $10,000-$49,999 for serving as a Intern Clinical application specialist at icometrix with The Prince Albert Fund.
Lakshmi Chauhan, MD	The institution of Dr. Chauhan has received research support from NIH. The institution of an immediate family member of Dr. Chauhan has received research support from University of Colorado.
Kelli Money, MD, PhD	Dr. Money has nothing to disclose.
Angela T. Kwan, MSc	Miss Kwan has nothing to disclose.
Ai A. Ohno, MD	Dr. Ohno has nothing to disclose.
Rauan Kaiyrzhanov, MD	Dr. Kaiyrzhanov has nothing to disclose.
Elelia Phillips, MD	Miss Phillips has nothing to disclose.
Dana Leifer, MD	Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Network. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum Partners. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agilence. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protembis. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Spigarelli Law Firm. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Anzalone Law Firm. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Finz & Finz. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for WIT Legal. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOAR. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pirotti &Glaat. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Brown& Barron. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Morris Williams. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Meyers Evans. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mandell & Schwartz. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Golomb & Honik. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Silver Glob & Teitell. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abramson Brown Dugan. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cochran Law Firm. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hackensack Meridian Health. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for KAMMCO. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kennedy Johnson. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Philips Parker. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Schochet . Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Walsh Woodard. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wicker Smith. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Yoeli Gottlieb. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Steven Friedman. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ross Feller Casey. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gentile & Associates. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dansker and Aspromonte. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Norman Steiner, Esq.. Dr. Leifer has stock in Landsdowne Labs. Dr. Leifer has stock in Neurotechnology Investors . The institution of Dr. Leifer has received research support from NIH.
Walter J. Molofsky, MD	Dr. Molofsky has nothing to disclose.
Bruce J. Day, MB, BS, F	No disclosure on file
Mark Faragher, MBBS, FRACP, FAAN	Dr. Faragher has stock in Argo P/L. Dr. Faragher has stock in Australian Foundation P/L. Dr. Faragher has stock in Argo Infrastructure P/L.
Shyam Visweswaran, MD	The institution of Dr. Visweswaran has received research support from NIH.
Lisa H. Sovory, MD	Dr. Sovory has nothing to disclose.
Shane Smyth, MD	Dr. Smyth has nothing to disclose.
Elspeth Hutton, FRACP, MBBS, PhD	The institution of Dr. Hutton has received research support from Lundbeck. The institution of Dr. Hutton has received research support from Daewoong Pharmaceuticals . The institution of Dr. Hutton has received research support from Xalud. The institution of Dr. Hutton has received research support from Ipsen. The institution of Dr. Hutton has received research support from Abbvie. The institution of Dr. Hutton has received research support from Cerecin. Dr. Hutton has a non-compensated relationship as a Board Member with Brain Foundation (Vic) that is relevant to AAN interests or activities. Dr. Hutton has a non-compensated relationship as a President-elect with Australian and New Zealand Headache Society that is relevant to AAN interests or activities.
David Dredge, MD	Dr. Dredge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Optum Rx. The institution of Dr. Dredge has received research support from NIH.
Michael S. Oldham, MD, MPH	Dr. Oldham has received personal compensation for serving as an employee of Praxis Precision Medicines.
Allison Little, PharmD	Dr. Little has received personal compensation for serving as an employee of Rapport Therapeutics.
Yasir P. Khan, MD	No disclosure on file
Jeremy Laukka, PhD	Dr. Laukka has nothing to disclose.
Mahima Kapoor, MD	The institution of Dr. Kapoor has received research support from Bethlehem Griffiths Research Foundation .
Nadia McMillan, MD, PhD	Dr. McMillan has nothing to disclose.
Mohammad A. Sheikh, MBBS	Dr. Sheikh has nothing to disclose.
Veronica Popescu, MD, PhD	The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Popescu has received research support from FWO.
Robert Stanton II, MD	The institution of Dr. Stanton has received research support from NIH.
David Robinson, MD	The institution of Dr. Robinson has received research support from NIH. The institution of Dr. Robinson has received research support from UC.
Sara Collorone	The institution of Sara Collorone has received research support from Rosetreest Trust. The institution of Sara Collorone has received research support from MAGNIMS/ECTRIMS.
Wenwen Zhang, MD, PhD	Dr. Zhang has nothing to disclose.
Davis L. Ewbank, DO	Dr. Ewbank has nothing to disclose.
Andersen Shemme, MD	Dr. Shemme has nothing to disclose.
Markus Hannan, MD	Dr. Hannan has nothing to disclose.
Muhammad I. Yousaf, MD	Dr. Yousaf has nothing to disclose.
Shikha Polega	Shikha Polega has received personal compensation for serving as an employee of UCB. Shikha Polega has stock in UCB. Shikha Polega has stock in Zogenix.
Emily Maly, MD	Dr. Maly has nothing to disclose.
Javier L. Galvan	Mr. Galvan has stock in Pfizer Inc. Mr. Galvan has stock in Butterfly Network Inc. Mr. Galvan has stock in Gilead Sciences Inc. Mr. Galvan has stock in Hyperfine Inc. Mr. Galvan has stock in MIrati Therapeutics Inc.
Mark Rosenberg, MD	Dr. Rosenberg has nothing to disclose.
Kelley Del Real	Kelley Dalby has received personal compensation for serving as an employee of Praxis Precision Medicines. Kelley Dalby has stock in Praxis Precision Medicines. Kelley Dalby has stock in RogCon.
Zachary Pardieck, MD	Dr. Pardieck has nothing to disclose.
Asad Ahrar, MD	Dr. Ahrar has nothing to disclose.
Renato Oliveira, MD	Dr. Oliveira has nothing to disclose.
Victor Bushlyar, MD	Dr. Bushlyar has nothing to disclose.
William J. Therriault	Mr. Therriault has nothing to disclose.
Katharine Dermigny, MD	Dr. Dermigny has nothing to disclose.
Jeffrey Kuerbitz, PhD	Dr. Kuerbitz has nothing to disclose.
Cynthia Grossman	Cynthia Grossman has received personal compensation for serving as an employee of Biogen. Cynthia Grossman has stock in Biogen .
Joyce Mbiziwo-Tiapo, MD	Dr. Mbiziwo-Tiapo has nothing to disclose.
Sally S. Ladsaria, MD	Dr. Ladsaria has nothing to disclose.
Tatum Moog	Miss Moog has nothing to disclose.
Odei Alayyas, MD	Dr. Alayyas has nothing to disclose.
Svend Geertsen, PhD	Dr. Geertsen has received personal compensation for serving as an employee of Sanofi.
Mohammad R. Ghani, MD	Dr. Ghani has nothing to disclose.
Daniel R. Thomases, PhD	Dr. Thomases has received personal compensation for serving as an employee of Sunovion Pharmaceuticals.
Sandra Badial	Ms. Badial has nothing to disclose.
Melissa H. Vega, MD	Dr. Vega has nothing to disclose.
Hayley G. Williams, MD	An immediate family member of Dr. Williams has stock in Jazz Pharmaceuticals.
Julyana M. Dantas, MD	Dr. Dantas has nothing to disclose.
Holly Sim, MD	Dr. Sim has nothing to disclose.
Ping Shi, MD	Dr. Shi has nothing to disclose.
Jonathan W. Handshoe, MD	Dr. Handshoe has nothing to disclose.
Akira Machida, MD, PhD	Dr. Machida has nothing to disclose.
Matthew W. Flounders, DO	Mr. Flounders has nothing to disclose.
Marina Creed	No disclosure on file
Naga V. Pathi Jagannatham, MD	Dr. Pathi Jagannatham has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Pathi Jagannatham has received personal compensation for serving as an employee of GlaxoSmithKline. Dr. Pathi Jagannatham has stock in Takeda Pharmaceuticals. Dr. Pathi Jagannatham has stock in GlaxoSmithKline.
Arturo I. Benitez, MD	Dr. Benitez has received personal compensation for serving as an employee of Takeda.
Bruno Padrazzi, MD	Dr. Sanofi has received personal compensation for serving as an employee of Sanofi. Dr. Sanofi has received personal compensation for serving as an employee of Sanofi. Dr. Sanofi has stock in Sanofi. Dr. Sanofi has stock in Sanofi.
Omar Elsekaily, MBBS	Dr. Elsekaily has nothing to disclose.
Elizabeth Evans, NP	Mrs. Evans has nothing to disclose.
Kriti Bhayana, MD	Dr. Bhayana has nothing to disclose.
Sojung Park, DO	Dr. Park has nothing to disclose.
Maria B. Grimberg, MD	Dr. Grimberg has nothing to disclose.
Michael F. Cronin	The institution of Mr. Cronin has received research support from American Heart Association.
Rachel Rhinehart, PA	Miss Rhinehart has nothing to disclose.
Alyssa Runco, MD	Dr. Domingue has nothing to disclose.
Muhammad Ayub, MD	Dr. Ayub has nothing to disclose.
Amal Abbes	Ms. Abbes has nothing to disclose.
Ayah Al-Bzour	Miss Al-Bzour has nothing to disclose.
Amanda Cyntia Lima Fonseca Rodrigues	Ms. Rodrigues has nothing to disclose.
Alankar Gupta, MD	Dr. Gupta has nothing to disclose.
Yaman Ahmed	Mr. Ahmed has nothing to disclose.
Ghayda'a N. Al-Majali	Ms. Al-Majali has nothing to disclose.
Ítalo B. Andrade	Mr. Andrade has nothing to disclose.
Omri Zveik, MD	Mr. Zveik has nothing to disclose.
Rodolfo M. Roman Guzman, Sr., MD	Dr. Roman Guzman has nothing to disclose.
Clarence Wade	Clarence Wade has nothing to disclose.
Gamaliel Aguilera Barragán Pickens, MD	Dr. Aguilera Barragán Pickens has nothing to disclose.
Ying-Chi S. Shen, MD	Dr. Shen has nothing to disclose.
Marc Lawrence, MD	Mr. Lawrence has nothing to disclose.
Gregory P. Devine, MD	Mr. Devine has nothing to disclose.
Karla Salazar, MD	Dr. Salazar has nothing to disclose.
Christina Massrey, MD	Dr. Massrey has nothing to disclose.
Douglas A. Wells, Jr., MD	Dr. Wells has nothing to disclose.
Mary Penckofer, MD	Ms. Penckofer has nothing to disclose.
Sean K. Wang	Mr. Wang has nothing to disclose.
Sophie Xie, MD	Ms. Xie has nothing to disclose.
Bryn Rubin, MD	Miss Rubin has nothing to disclose.
Galen Postma	No disclosure on file
Mouhamad Hammami	Mr. Hammami has nothing to disclose.
Nihas R. Mateti	Mr. Mateti has nothing to disclose.
Ryoichi Inoue, MD	Dr. Inoue has nothing to disclose.
Sama Noroozi Gilandehi, MD	Dr. Noroozi Gilandehi has nothing to disclose.
Despoina Ioannidou, PhD	Dr. Ioannidou has received personal compensation for serving as an employee of Therapanacea.
Rudy Luna, MD	Dr. Luna has nothing to disclose.
Sumayya Mohammed, MD	Miss Mohammed has nothing to disclose.
Noora C. Haghighi, MS	Miss Haghighi has nothing to disclose.
Hajera Naveed	Ms. Naveed has nothing to disclose.
Anh-Tho Antoinette T. Nguyen	Miss Nguyen has nothing to disclose.
Mehriban Sariyeva	Mrs. Sariyeva has nothing to disclose.
Taylor Ariko	Ms. Ariko has nothing to disclose.
Artur Menegaz de Almeida, MS	Mr. Menegaz de Almeida has nothing to disclose.
Kyriakoula Varmpompiti, MBBS	Dr. Varmpompiti has nothing to disclose.
Trieste Francis	Miss Francis has nothing to disclose.
Aarti R. Katara	Ms. Katara has nothing to disclose.
Ariel Rechtman	Ariel Rechtman has nothing to disclose.
Hejiao Mao	Hejiao Mao has nothing to disclose.
Alexander J. Mills	Mr. Mills has nothing to disclose.
Brendan Hare, PhD	Mr. Hare has received personal compensation for serving as an employee of Click Therapeutics, Inc..
Banafsheh Shakibajahromi, MD	Dr. Shakibajahromi has nothing to disclose.
Ishah Yusaf, Other	Ms. Yusaf has nothing to disclose.
Herbert Peeples II, Other	Mr. Peeples has received personal compensation for serving as an employee of UCB.
Wencheng Zhu	No disclosure on file
Khushalee Oza	Miss Oza has nothing to disclose.
Xiangmin Fan	No disclosure on file
Juanjuan Wu, Other	Dr. Wu has nothing to disclose.
Victor Soto Insuga	No disclosure on file
Yasmine Saad	No disclosure on file
Saba Azizi Torkanpour	Miss Azizi Torkanpour has nothing to disclose.
Jacob D. Baraz	Mr. Baraz has nothing to disclose.
Paloma Oliveira	No disclosure on file
Allan Polverini	No disclosure on file
Dimitrios Bourikas	Dr. Bourikas has nothing to disclose.
Lindsay Berg, Other	Ms. Berg has nothing to disclose.
Nicholas Vigilante III, MD	Mr. Vigilante has nothing to disclose.
Eileen Xu	Miss Xu has nothing to disclose.
Alexander Kuka	Dr. Kuka has received personal compensation for serving as an employee of Click Therapeutics, Inc..
Faissal Stipho	Mr. Stipho has nothing to disclose.
Anam K. Shaikh	Miss Shaikh has nothing to disclose.
Carlos Alberto Campello	No disclosure on file
Pascal Sati	The institution of Pascal Sati has received research support from National Multiple Sclerosis Society. The institution of Pascal Sati has received research support from National Institutes of Health . The institution of Pascal Sati has received research support from Erwin Rautenberg Fondation. The institution of Pascal Sati has received research support from Department of Defense. Pascal Sati has received intellectual property interests from a discovery or technology relating to health care. Pascal Sati has received publishing royalties from a publication relating to health care.
Arun Aggarwal, FRACP	Prof. Aggarwal has nothing to disclose.
Conor Reid	Mr. Reid has nothing to disclose.
Jade Marshall	No disclosure on file
Olya Besedina	Miss Besedina has nothing to disclose.
Lili Ding	No disclosure on file
Amir Mina	Mr. Mina has received intellectual property interests from a discovery or technology relating to health care.
Gabriel Marinheiro Dos Santos-Bezerra	Gabriel Marinheiro Dos Santos-Bezerra has nothing to disclose.
Shivani Daryani, PA	Ms. Daryani has nothing to disclose.
Shayna Pehel	Ms. Pehel has nothing to disclose.
Saja Alzghoul	Miss Alzghoul has nothing to disclose.
Jiyuan Hu	Jiyuan Hu has nothing to disclose.
Filipa Carvalho	No disclosure on file
Fumihiro Watanabe	No disclosure on file
Madison M. Patrick	Ms. Patrick has nothing to disclose.
Zaid M. Khalefa	Mr. Khalefa has nothing to disclose.
James Strathdee, MBBS	Dr. Strathdee has nothing to disclose.
Mark Hester, PhD	Dr. Hester has nothing to disclose.
Refaat E. Gabr, PhD	Dr. Gabr has received personal compensation for serving as an employee of Biogen. Dr. Gabr has stock in Biogen.
William Drew	Mr. Drew has nothing to disclose.
Ciara Hupp, MD	Ms. Hupp has nothing to disclose.
Mingyu Tang	Mingyu Tang has nothing to disclose.
Isabelle Preddy, MD	Ms. Preddy has nothing to disclose.
Herve Besson	Herve Besson has received personal compensation for serving as an employee of UCB.
Marisa M. Modjeski	Miss Modjeski has nothing to disclose.
Anna Sosa	Anna Sosa has nothing to disclose.
Duane Berkompas	No disclosure on file
Brenda Trokthi	No disclosure on file
Elizabeth Haddad, MS	Miss Haddad has nothing to disclose.
Jenny Qian	Jenny Qian has nothing to disclose.
Tejas Patel	No disclosure on file
William Harmsen	William Harmsen has nothing to disclose.
Cristina Villa	No disclosure on file
Arenn Faye Carlos, MD	The institution of Dr. Carlos has received research support from American Academy of Neurology.
Shivam Patel, MD	Mr. Patel has nothing to disclose.
Brian Dewar	No disclosure on file
Christopher Kenney	No disclosure on file
Jiangxia Zhang	No disclosure on file
Marcio Souza	Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
Mallory Alonso, PharmD	Dr. Alonso has received personal compensation for serving as an employee of UCB, Inc.. Dr. Alonso has stock in UCB, Inc..
Sydney Vivanco	Mrs. Vivanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Mrs. Vivanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Mrs. Vivanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Mrs. Vivanco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Mrs. Vivanco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Dhara Mehta, DO	Dr. Mehta has nothing to disclose.